Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.
Open | $14.76 |
Close | $14.33 |
Volume / Avg. | 318.49K / 539.84K |
Day Range | 14.16 - 14.77 |
52 Wk Range | 10.49 - 28.80 |
Market Cap | $714.21M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 12.79% |
Days to Cover | 8.65 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.
Other companies in Regenxbio’s space includes: Celcuity (NASDAQ:CELC), Replimune Group (NASDAQ:REPL), Sage Therapeutics (NASDAQ:SAGE), Olema Pharmaceuticals (NASDAQ:OLMA) and Emergent BioSolutions (NYSE:EBS).
There is no analysis for Regenxbio.
Regenxbio has a consensus price target of $44.07.
The stock price for Regenxbio (NASDAQ: RGNX) is $14.5 last updated July 26, 2024 at 5:58 PM EDT.
There are no upcoming dividends for Regenxbio.
Regenxbio’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Regenxbio.
Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.